Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer
Eva Balslev
Dorte L. Nielsen
Malgorzata K. Tuxen
Soeren Cold
Ulla B. Tange
10.6084/m9.figshare.1623064.v1
https://tandf.figshare.com/articles/journal_contribution/Phase_II_study_of_neoadjuvant_pegylated_liposomal_doxorubicin_and_cyclophosphamide_177_trastuzumab_followed_by_docetaxel_in_locally_advanced_breast_cancer/1623064
Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer
2014-10-01 00:00:00
phase II study
docetaxel
trastuzumab
cyclophosphamide
breast cancer Phase II study
neoadjuvant pegylated liposomal doxorubicin